logo
Hair loss and semaglutides: How GLP-1s, as well as age and genetics, can make your hair fall out

Hair loss and semaglutides: How GLP-1s, as well as age and genetics, can make your hair fall out

The National30-04-2025

It's a condition that's been around as long as humans have been hirsute, but thinning hair has been making headlines over the past year, thanks to the global increase in the use of GLP-1 weight loss medicines. Conversations about thinning hair have traditionally been centred around age, hormonal changes, genetics, stress levels and lifestyle, but these days, online forums are awash with people who use GLP-1's such as Ozempic, Mounjaro and Wegovy, sharing stories about hair loss along with their weight loss. Hair thinning and hair loss differ according to a number of factors, individual and environmental, and men and women experience the condition, known as alopecia, differently. 'Hair thinning tends to become more common after the age of 40, although younger individuals may also be affected due to lifestyle or medical factors,' says Dr Mohammed Zahir, specialist dermatology and cosmetology, Aster Clinic, Bur Dubai. 'Early signs differ by gender. In men, thinning usually starts with a receding hairline and hair loss around the crown. In women, a common indicator is the widening of the central hair part, accompanied by overall thinning, particularly on the top of the scalp.' GLP-1s have been used since 2005 to treat type 2 diabetes, but it wasn't until 2014 that the link between the drug and weight loss was established. In 2017, Ozempic was approved by the US Food and Drug Administration for use in adults with type 2 diabetes, and since then, semaglutides have become household names. The relative newness of the medication when used for weight loss means the connection between semaglutides and hair loss is so far largely anecdotal, although a new study out of Canada in March 2025, Risk of Hair Loss with Semaglutide for Weight Loss, which focused on Wegovy users, established a firmer connection. 'We adjusted for age, sex, geographic location, depression, steroid use, hypothyroidism, polycystic ovary syndrome and anaemia,' states the report lead by Dr Mohit Sodhi, a resident in emergency medicine at University of British Columbia. 'The incidence of hair loss was higher among the semaglutide group than the active comparator… Our results demonstrate an increased risk of hair loss with semaglutide in women.' Little is known about why using GLP-1s can lead to hair thinning or loss, with a September 2024 study, GLP-1 agonists and hair loss: A call for further investigation noting: 'Some propose potential risks such as disrupted hair growth cycles or premature androgenetic alopecia (AGA), while others suggest benefits linked to improved insulin sensitivity and enhanced scalp blood circulation. Despite these theoretical underpinnings, clinical evidence linking GLP-1 agonists to hair loss remains sparse.' 'Hair thinning can indeed occur as a side effect of GLP-1 medications, but it is typically not a direct result of the medication itself,' says Dr Dilruba Begum Mujavar Shaik, specialist dermatologist at RAK Hospital. 'Instead, it is often linked to rapid weight loss associated with these treatments. This phenomenon is known as 'telogen effluvium', a temporary condition where hair follicles enter a resting phase due to physical stress on the body. The good news is that it's usually temporary. Hair growth typically resumes within three to six months after the body adjusts and weight stabilises.' Hair loss or thinning is caused by an array of factors and differs by gender, with men and women experiencing hair loss in different ways. 'Men typically experience androgenetic alopecia, commonly known as male pattern baldness, which presents as receding hairlines and thinning on the crown due to genetic sensitivity to DHT (dihydrotestosterone, a hormone that plays a key role in male sexual development),' says Dr Jasmin Malek, women's health and hormone therapy expert at Euromed Clinic Dubai. 'In women, hair thinning is more diffuse, often a general reduction in volume rather than complete bald spots. Female pattern hair loss is influenced by declining oestrogen and progesterone levels, especially around perimenopause and menopause, which disrupt the natural protection these hormones provide to hair follicles.' Other factors include genetics, whereby thinning hair is hereditary, chemical hair treatments, environmental aspects such as infection, weather and water; underlying health conditions including anaemia, hypothyroidism and vitamin deficiency and pregnancy. 'Stress is more than just a mental burden – it has physical consequences, including on our hair,' says Dr Victoria Mountford, psychology lead and eating disorder service lead at Sage Clinics. 'When we experience ongoing psychological stress, the body releases higher levels of cortisol, the stress hormone. This disrupts the normal hair growth cycle, often pushing more hair into the resting phase, which leads to increased shedding.' She adds: 'In fast-paced environments like the UAE, where many of us juggle demanding careers and personal responsibilities, chronic stress is a common – but often overlooked – contributor to hair issues.' Tackling the underlying causes of stress is key to ending the cycle of stress-related hair loss, with Dr Zahir noting: "Fortunately, this type of hair loss is often temporary and reversible with proper stress management and care.' Experts suggest relaxation techniques, a balanced diet and professional guidance as the best ways to manage stress. 'Mindful prayer or meditation, breathwork, daily movement, screen-free wind-down time and connection all have proven stress-relieving benefits,' says Dr Mountford. 'Making sure your diet includes protein, zinc and biotin will support hair health.' 'I have indeed noticed an increase in hair loss due to weight loss injections,' says Maria Dowling, founder of Mariadowling Salon Dubai, of her clients. 'The negative impacts of these injections on hair can vary between clients. I have two clients who had really curly hair, and as a result of the jabs, their hair has lost the curl pattern and instead is now frizzy. In other instances, clients have simply lost hair.' Medically, hair loss is treated with oral or topical medications, hormonal therapy, dietary changes and environmental adjustments. Dr Malek says: 'The best approach is multifactorial and tailored to the individual. In menopausal women, restoring hormonal balance with BHRT can reduce shedding and promote regrowth. Nutritional support such as iron, zinc, biotin, vitamin D and amino acids like L-lysine are all crucial for hair structure and cycling. Advanced regenerative options include PRP, Exosomes, and Regenera Activa – minimally invasive treatments now gaining popularity for restoring scalp health.'

Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

Hypertension alert: Know your blood pressure, take care of your heart
Hypertension alert: Know your blood pressure, take care of your heart

Khaleej Times

time29-05-2025

  • Khaleej Times

Hypertension alert: Know your blood pressure, take care of your heart

Hypertension, or high blood pressure, affects over 1.28 billion people globally and is a leading cause of heart attacks, strokes, and kidney failure. Often symptomless, it's known as the 'silent killer,' silently damaging vital organs over time. In the UAE, lifestyle factors like poor diet, stress, and physical inactivity are fuelling its rise, with nearly one in three adults affected. As we mark 20 years of World Hypertension Day, this year's theme — 'Measure Your Blood Pressure Accurately, Control It, Live Longer' — reminds us that early detection, accurate monitoring, and lifestyle changes are key to long-term heart health. 'Your plate can either protect your heart or pressure it,' says Vibha Bajpaiee, Clinical Dietician at Aster Clinic, Bur Dubai (AJMC). 'A diet low in salt, saturated fats, and processed foods, but rich in fruits, vegetables, whole grains, and potassium-rich foods, helps regulate blood pressure naturally. Avoid sugary drinks and excess caffeine. Opt for home-cooked meals with herbs instead of salt for flavour. Keep an eye on food labels — hidden sodium is common. Hydration, portion control, and mindful snacking also play key roles. Combine smart eating with regular movement, and you create a strong defence against hypertension. Remember, what you eat today can shape your heart health tomorrow.' Know your numbers: Why regular BP checks should be your daily habit Dr Heba Tag Eldin, Specialist Cardiology at Aster Clinic, Halwan (Sharjah), says: 'High blood pressure rarely shows symptoms, which is why regular monitoring is crucial.' 'Measuring your blood pressure accurately at home or in a clinic helps detect abnormalities early, often before complications develop. Aim to check at the same time each day, in a relaxed state, and use a validated device. Record your readings to spot trends. Knowing your numbers empowers you to take proactive steps — whether through lifestyle changes or medication. Don't wait for symptoms; prevention begins with awareness. Early action based on accurate readings can help you avoid long-term damage to your heart, brain, and kidneys.' From salt to stress: Blueprint for a heart-healthy lifestyle 'Managing high blood pressure begins with sustainable lifestyle changes,' says Dr Ashik Sasidharan, Specialist Cardiology at Aster Clinic, Al Qusais (Damascus St.). 'Reduce salt intake to less than 5g a day, maintain a healthy weight, and exercise regularly — aim for at least 30 minutes of moderate activity most days. Limit alcohol, quit smoking, and manage stress through mindfulness, breathing exercises, or hobbies you enjoy. Sleep is equally important; poor rest can increase blood pressure. Monitor your intake of caffeine and processed foods, which can trigger spikes. Lifestyle choices may seem small, but collectively, they can significantly lower blood pressure, improve heart function, and reduce your need for long-term medication.' The kidney connection: How high blood pressure wreaks silent havoc 'Hypertension is a major contributor to chronic kidney disease, often causing silent, progressive damage over time,' says Dr Azeem Ahamed, Specialist Nephrology at Aster Clinic, Bur Dubai (AJMC), and Aster Cedars Hospital & Clinic, Jebel Ali. 'When blood pressure remains elevated, it puts extra strain on the delicate vessels in the kidneys, reducing their ability to filter waste effectively. Over time, this can lead to kidney failure. Regular kidney function tests and urine checks can help detect early damage. Managing your blood pressure through diet, lifestyle, and medication is essential to protect kidney health. Hydrate well, limit salt and processed foods, and avoid overuse of painkillers, which can worsen kidney function. Healthy blood pressure supports healthy kidneys — for life.' Pressure builds silently: Early signs you should never ignore Dr Sachin Upadhyaya, Specialist Cardiology at Aster Hospital, Mankhool, says: 'Though hypertension is often symptomless, some people may experience subtle signs like frequent headaches, nosebleeds, blurred vision, chest discomfort, or shortness of breath.' He further explains 'These should not be dismissed. If you're at risk due to family history, obesity, stress, or poor lifestyle habits, regular screening becomes even more essential. Left unmanaged, high blood pressure can silently damage arteries and vital organs. According to the latest 2024 ESC guidelines, even patients with BP above 120/70 mmHg should undergo risk evaluation and begin treatment if found high-risk. If you notice these early indicators, seek medical evaluation immediately. It's better to investigate mild symptoms than wait for a crisis. Timely detection and early intervention can prevent irreversible heart, brain, or kidney complications.' Prepping the heart: Why controlled BP is crucial before surgery Dr Anil P Kumar, Specialist Interventional Cardiology at Aster Hospital, Qusais, says: 'For patients undergoing cardiac or any major surgery, optimal blood pressure control is non-negotiable.' 'Uncontrolled hypertension increases the risk of bleeding, stroke, heart attack, and complications during anaesthesia. Before surgery, a thorough assessment — including blood pressure monitoring—is performed to stabilise the patient. Medications may need adjusting, and lifestyle changes may be recommended in the lead-up to the procedure. Preoperative control of blood pressure improves surgical outcomes, reduces ICU stays, and speeds up recovery. If you're scheduled for surgery, work closely with your healthcare provider to bring your blood pressure within target range well before your operation.' Inside the OR: How surgeons handle hypertension-compromised hearts 'Operating on a heart burdened by years of high blood pressure poses unique challenges,' says Dr Debabrata Dash, Consultant Interventional Cardiology at Aster Hospital, Mankhool. 'Chronic hypertension leads to thickened heart walls, stiff arteries, and a higher risk of bleeding during surgery. Surgeons must anticipate complications like arrhythmias or reduced heart function. Intraoperative blood pressure must be managed meticulously to avoid sudden drops or spikes. Every second in the operating room is calculated, and surgical plans are customised for hypertensive patients. Timely surgical intervention, supported by a multidisciplinary team, helps stabilise cardiac function and prevent catastrophic outcomes. Managing hypertension before and after surgery is vital to long-term recovery.' Post-op and beyond: Managing hypertension after cardiac surgery Dr Srinivasan Kandasamy, Specialist Cardiology at Aster Hospital, Qusais, says: 'Recovery from cardiac surgery doesn't end in the hospital — it extends into daily life.' 'Managing blood pressure post-surgery is essential to protect your surgical outcomes and prevent recurrence. Follow your medication schedule strictly, attend follow-up appointments, and maintain a low-sodium, heart-healthy diet. Gradually return to physical activity under medical guidance. Track your blood pressure regularly and watch for signs like swelling, fatigue, or dizziness. Mental well-being matters too — address anxiety or depression, which can affect your BP. With consistent effort, many patients achieve better blood pressure control post-surgery than before. Long-term success lies in disciplined, proactive care.' At Aster Hospitals and Clinics, we are committed to raising awareness, enabling early detection, and delivering expert care for hypertension. By prioritising accurate monitoring and heart-healthy living, we aim to empower our community to take control of their blood pressure — and their future. Your heart health starts with Aster.

Zuellig Pharma Launches Lilly's Innovative Obesity and Diabetes Medicine in Thailand
Zuellig Pharma Launches Lilly's Innovative Obesity and Diabetes Medicine in Thailand

Zawya

time27-05-2025

  • Zawya

Zuellig Pharma Launches Lilly's Innovative Obesity and Diabetes Medicine in Thailand

Mounjaro® (tirzepatide) will be available in the market from the end of May 2025 BANGKOK, THAILAND - Media OutReach Newswire - 27 May 2025 - Zuellig Pharma, a leading healthcare solutions company in Asia, has announced that Mounjaro ® (tirzepatide), the innovative obesity and diabetes medicine developed by Eli Lilly and Company, will be launched in Thailand at the end of May 2025. Zuellig Pharma holds the marketing authorization for Mounjaro ® (tirzepatide) in Thailand, having been granted the distribution and promotion rights for the medicine by Eli Lilly and Company this year. Mounjaro ® (tirzepatide) is a once-weekly prescription-only medicine indicated for the treatment of adults with insufficiently controlled type 2 diabetes mellitus as an adjunct to diet and exercise; as monotherapy when metformin is considered inappropriate due to intolerance or contraindications, in addition to other medicinal products for the treatment of diabetes; and as an adjunct to a reduced-calorie diet and increased physical activity for weight management, including weight loss and weight maintenance, in adults with an initial Body Mass Index (BMI) of ≥30 kg/m 2 (obesity) or ≥27 kg/m2 to < 30 kg/m 2 (overweight) in the presence of at least one weight-related comorbid condition (e.g., hypertension, dyslipidemia, obstructive sleep apnea, cardiovascular disease, prediabetes, or type 2 diabetes mellitus). The availability of Mounjaro ® (tirzepatide) is a significant advancement in the treatment of both obesity and type 2 diabetes, offering a single medication that can address both conditions through an easy-to-use prefilled pen. Mounjaro ® KwikPen ® (tirzepatide injection) is available in 2.5 mg, 5 mg, 7.5 mg and 10 mg, and gives healthcare providers the ability to personalize treatment plans better to meet individual patient needs. Obesity is a critical public health concern in Thailand that affects 48% of the total population. 2 The Ministry of Public Health classifies obesity as a Non-Communicable Disease (NCD) due to its strong link to rising rates for chronic illnesses, particularly type 2 diabetes. In 2024, the Department of Disease Control reported that 1 in 10 Thai individuals – a total of 6.5 million people – suffer from type 2 diabetes, impacting their physical, mental, and social well-being. 2 People with diabetes face significant challenges in managing their blood sugar and preventing complications such as cardiovascular disease, chronic kidney disease, diabetic retinopathy, and diabetic foot ulcers, which can lead to severe infections and potential amputation. 3 "Obesity and diabetes have gained prominence as significant health challenges in Thailand, and we are excited to accelerate the availability of Mounjaro ® (tirzepatide) to patients in the region. With our deep understanding of the local regulatory landscape, as well as our proven track record of delivering innovative healthcare solutions in unmet disease areas, we are well placed to enhance the availability of the medicine in the market. This represents a significant step forward in our commitment to making healthcare more accessible, particularly in the chronic metabolic disease market," said Rehan Saghir, Executive Vice President of Zuellig Pharma's Commercialization division. References: Mounjaro. Prescribing Information. Eli Lilly Asia, Inc. Division of Non-communicable Disease, Department of Disease Control, Ministry of Public Health) Yang, T., Qi, F., Guo, F. et al. An update on chronic complications of diabetes mellitus: from molecular mechanisms to therapeutic strategies with a focus on metabolic memory. Mol Med 30, 71 (2024). Hashtag: #ZuelligPharma #EliLillyandCompany #Diabetes #Obesity #Healthcare #Pharmaceuticals The issuer is solely responsible for the content of this announcement. About Zuellig Pharma Zuellig Pharma is a leading healthcare solutions company in Asia, and our purpose is to make healthcare more accessible to the communities we serve. We provide world-class distribution, digital and commercial services to support the growing healthcare needs in this region. The company was started a hundred years ago and has grown to become a multibillion-dollar business covering 17 markets with over 12,000 employees. Our people serve more than 200,000 medical facilities and work with over 450 clients, including the top 20 pharmaceutical companies in the world. For more information, visit: Zuellig Pharma

How GLP-1 weight loss drugs like Ozempic are changing restaurant culture
How GLP-1 weight loss drugs like Ozempic are changing restaurant culture

Khaleej Times

time20-05-2025

  • Khaleej Times

How GLP-1 weight loss drugs like Ozempic are changing restaurant culture

Michael Foote was at dinner with three friends at Soothr, a Thai restaurant in the East Village of Manhattan, when he looked up and noticed he was the only one eating. 'We had all ordered all this food, and we were all sharing everything,' he said, 'but I was chowing down, and my friends were all taking these little baby bites.' All of his dining companions were on GLP-1s, a class of drugs that are increasingly used for weight loss. Most people who take them report feeling hungry less often, and when they do eat, they can feel extremely full after a few bites. Foote, a lawyer, said that the majority of his friends are on these medications, creating a new dynamic when they go out to eat. They usually order appetizers and entrees to share; his friends will take a few bites, and he will finish the rest. 'I am a 6-foot-4, 210-pound guy, and I get quite hungry,' said Foote, 36, with a laugh. They still dine out often, 'even though it's a complete charade for them.' As long as they still split the bill — which they usually do — he is fine with the arrangement. 'I think if I were a more self-conscious person, I would care that I was the only person being a little Miss Piggy over here,' he said. 'But I love food. Some people eat to live. I love to eat.' Morgan Stanley Research analysts estimate that 24 million people, or 7 per cent of Americans, will be taking a GLP-1 by 2035. As weight-loss drugs soar in popularity, diners on and off them are wrestling with a number of restaurant etiquette quandaries, and in some cases changing their dining habits as a result. Diners on GLP-1s are figuring out which types of restaurants they feel comfortable visiting; how to leave food on their plates without insulting the chef or their dining companions; and how to get the most value out of the experience. Those not on the drugs are contending with the pros and cons of going out with people who don't do much eating. 'There is a social component to this,' said David Wiss, a nutritionist in Los Angeles with a doctorate in public health. 'We are in a period of flux and change, and people are learning how to navigate this.' Nine months ago, Will Farmer, a talent agent in London, started taking the diabetes drug Mounjaro, a GLP-1 that many have used off-label to lose weight. Shortly after, he went to a 10-course tasting meal for a work event and could only eat a little of each course. 'I was eating a quarter of a Scotch egg,' he said. The restaurant emailed the event's host to ask if everything was OK. 'They were worried I found the food disgusting,' said Farmer, 34. Now he eats only at restaurants that serve family-style dishes or small plates so it isn't as obvious when he doesn't finish his food. 'If you go to a steak restaurant, it's weird if you leave most of it,' he said. 'But when we are all sharing, the food disappears and it's not this individual shame of leaving food behind.' As a self-described foodie in New York City, Lauren Wire loves to go out to eat and order a lot of dishes. 'I want to try everything,' she said. But as soon as she sits down, she warns everyone from the server to her dining companions that she is on a GLP-1. 'The chef might come out to say hi, or I might be on a date, and I will joke that I need a box because I am on Ozempic,' said Wire, 36. 'I don't want them to think I don't like the food, and also I want to normalise this.' It's all worth the leftovers: She likes that she can save money and enjoy the same amount of food over a longer stretch of time. Wire thinks those who dine with her and are not on the drugs only benefit. 'I still over-order, and then they get to eat more of my food,' she said, laughing. Non-dinner meetings have been the hardest for Joseph Suchodolski, a fashion consultant in New York City who has taken Mounjaro for more than two years to treat his diabetes. He tends to snack during the day, and will often insist on having just a coffee at a breakfast meeting. But during a recent morning meeting in Los Angeles, he learned his companion was also on a GLP-1. 'We both ordered breakfast, and we were just moving it around the plate,' said Suchodolski, 38. When they finally shared why, they started laughing and opening up. Wiss said it's important for patients who are new to GLP-1s to consider how they might handle social situations that can arise from eating less in public. 'When people stop drinking alcohol, for example, it's helpful for them to think through how they will respond when people offer them a drink or a waiter is disappointed they don't order grape,' he said. 'We are seeing that re-created with food.' Some people say GLP-1s have improved the experience of eating at restaurants, though. After struggling with childhood obesity, Jackson Lemay, a content creator in Atlanta, used to feel anxious that he was eating too fast or too much while dining out. He would obsess over the menu before he got to the restaurant and shame himself if he ordered something unhealthy or too large. After taking a GLP-1 for a year and a half, that 'food noise' is gone. 'It has made me feel more confident in eating in public,' said Lemay, 27. He has never enjoyed restaurants as much as he does now. There are some people not on the drugs who refuse to dine out with people on them, though they were hesitant to say so on the record. They say they're embarrassed by full plates sent back to the kitchen, or insecure about eating more than the person across the table. But Nathaly del Carmen loves being around people with smaller appetites. Her mother, sister and many of her friends are on GLP-1s, and she estimates that at least one person at her table is on them whenever she dines out. Del Carmen, a marketing manager in New York, said she finds herself mirroring the behavior of those on the drugs, which means she eats less and doesn't feel pressure to finish her meal if she isn't hungry. 'It helps me with impulse control,' she said.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into the world of global news and events? Download our app today from your preferred app store and start exploring.
app-storeplay-store